Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1201935-36-5

Post Buying Request

1201935-36-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1201935-36-5 Usage

Description

1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine is a chemical compound with the molecular formula C10H16N4. It is a pyrazole derivative and contains a methylpiperidine group. 1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine is significant in medicinal chemistry due to its selective inhibitory activity on certain enzymes, which positions it as a potential candidate for drug development. Its unique structure and properties make it a promising substance for further research and development within the pharmaceutical industry.

Uses

Used in Pharmaceutical Industry:
1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine is used as a research compound for its selective inhibitory activity on certain enzymes. This characteristic makes it valuable in the development of new drugs, particularly those targeting specific enzyme pathways related to various diseases.
Used in Drug Development:
In the field of drug development, 1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine serves as a potential lead compound. Its ability to selectively inhibit certain enzymes suggests that it could be instrumental in creating targeted therapies for conditions where these enzymes play a critical role in disease progression.
Used in Medicinal Chemistry Research:
1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-aMine is utilized as a subject of study in medicinal chemistry research. Scientists investigate its interactions with biological targets to understand its potential therapeutic applications and to design more effective drugs based on its chemical structure.

Check Digit Verification of cas no

The CAS Registry Mumber 1201935-36-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,9,3 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1201935-36:
(9*1)+(8*2)+(7*0)+(6*1)+(5*9)+(4*3)+(3*5)+(2*3)+(1*6)=115
115 % 10 = 5
So 1201935-36-5 is a valid CAS Registry Number.

1201935-36-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(1-Methylpiperidin-4-yl)-1H-pyrazol-4-amine

1.2 Other means of identification

Product number -
Other names 1-(1-methylpiperidin-4-yl)pyrazol-4-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1201935-36-5 SDS

1201935-36-5Relevant articles and documents

FGFR Inhibitor compounds and uses thereof

-

, (2021/11/21)

The invention relates to FGFR inhibitor compounds and uses thereof. , The application discloses a compound as shown in a formula (I). A compound, or an optical isomer, a geometric isomer, a tautomer or isomer mixture thereof, or a pharmaceutically acceptable salt thereof, or a prodrug thereof, or a metabolite thereof. The application further relates to the application of the compound in medicine.

Heterocyclic compound as well as preparation method and medical application thereof

-

, (2021/01/11)

The invention relates to a heterocyclic compound suitable for inhibiting or regulating Janus family kinase (JAK), in particular tyrosine kinase 2 (TYK2), a preparation method of the heterocyclic compound and application of the heterocyclic compound in medicine. Specifically, the present invention relates to a compound represented by a general formula (I), a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound or the pharmaceutically acceptable salt thereof, and a method of using the compound or the pharmaceutically acceptable salt thereof to treat and/or prevent Janus kinase-mediated related diseases, especially autoimmune diseases, inflammatory diseases and cancers and a method for preparing the compound or pharmaceutically acceptable salt thereof. The invention also relates to application of the compound or the pharmaceutically acceptable salt thereof or the pharmaceutical composition containing the compound or the pharmaceutically acceptablesalt thereof in preparation of drugs for treating and/or preventing Janus kinase mediated related diseases, especially autoimmune diseases, inflammatory diseases and cancers. Each substituent of thegeneral formula (I) is as defined in the specification.

HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

-

Paragraph 000231, (2020/11/30)

Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers. (I)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1201935-36-5